Loading...

Home
ETF
AMRX

AMRX

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

AMRX News

Amneal Pharmaceuticals Advances Drug Development with Positive ELEVATE-PD Results

Jun 13 2026Yahoo Finance

Biotech Sector Sees Surge in FDA and Global Approvals

Jun 12 2026NASDAQ.COM

Amneal's Commitment to Reliable Medicine Supply for Uninsured Patients

Jun 10 2026PRnewswire

Amneal Supports Hope Alliance Campaign to Ensure Medicine Supply

Jun 10 2026Newsfilter

CREXONT Phase 4 Study Shows Significant Clinical Benefits

Jun 05 2026Newsfilter

Amneal Receives Approval for New Romidepsin Injection Solution

Jun 04 2026Newsfilter

Amneal Pharmaceuticals Q1 2026 Earnings Exceed Expectations

May 08 2026seekingalpha

Analysis of Risks and Opportunities in Value Stock Investment

May 04 2026Yahoo Finance

Amneal Pharmaceuticals Q1 Earnings Preview

Apr 30 2026seekingalpha

Amneal Pharmaceuticals Acquires Kashiv BioSciences, Paving the Way for Biosimilars Integration

Apr 22 2026seekingalpha

U.S. Stocks Rise, Nasdaq Hits Record High

Apr 22 2026NASDAQ.COM

U.S. Stocks Rise, Nasdaq Hits Record High

Apr 22 2026NASDAQ.COM

Amneal Acquires Kashiv BioSciences for $750M, Boosts Revenue Guidance

Apr 22 2026seekingalpha

Amneal to Acquire Kashiv, Creating a Global Biosimilars Platform

Apr 22 2026Newsfilter

Amneal Acquires Kashiv BioSciences to Capitalize on $300B Global Biologics Market

Apr 22 2026Newsfilter

UBS Initiates Buy Rating on Amneal Pharmaceuticals with $19 Price Target

Apr 20 2026seekingalpha